Peru

Peru

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.51 (1.18 - 1.90) 2015 Modelled WHO
0.3 (0.30 - 0.40) 2016 Modelled Razavi-Shearer et al, 2018
0.4 (0.21 - 0.55) 2015 Survey/reported Cabezas, C., et al. 2020
2.1 (1.90 - 2.32) 2013 Modelled Schweitzer et al, 2015
0.5 (0.46 - 0.55) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.57 (0.52 - 0.64) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.53 - 0.65) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.53 - 0.64) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.53 - 0.64) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.53 - 0.64) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.54 - 0.65) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.54 - 0.65) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.55 - 0.66) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.55 - 0.67) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.55 - 0.67) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.55 - 0.68) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.56 - 0.69) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.56 - 0.69) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.55 - 0.70) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.56 - 0.70) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.55 - 0.69) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.56 - 0.69) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.56 - 0.69) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.55 - 0.69) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.55 - 0.69) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.56 - 0.68) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.56 - 0.69) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.56 - 0.69) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.55 - 0.70) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.55 - 0.69) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.55 - 0.69) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.54 - 0.68) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.54 - 0.68) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.54 - 0.67) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.51 - 0.62) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.24 (0.16 - 0.35) 2015 Modelled WHO
0.04 (0.03 - 0.05) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.06 (0.04 - 0.07) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.08) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.09) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.11) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.07 - 0.13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.08 - 0.15) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.16) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.09 - 0.17) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.18) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.10 - 0.18) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.10 - 0.19) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.20) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.12 - 0.21) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.13 - 0.23) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.15 - 0.26) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.16 - 0.28) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.23 (0.17 - 0.29) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.23 (0.17 - 0.29) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.23 (0.17 - 0.29) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.23 (0.17 - 0.29) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.23 (0.17 - 0.29) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.16 - 0.29) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.07) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of persons living with chronic HBV

National
Download
Value Year Type Source
92,000 (81,000 - 127,000) 2016 Modelled Razavi-Shearer et al, 2018
169,711 (155,721 - 188,009) 2019 Modelled IHME, GBD 2019 (accessed 2020)
180,112 (165,857 - 199,214) 2019 Modelled IHME, GBD 2019 (accessed 2022)
183,598 (168,372 - 203,974) 2018 Modelled IHME, GBD 2019 (accessed 2022)
183,893 (166,092 - 205,297) 2017 Modelled IHME, GBD 2019 (accessed 2022)
181,005 (164,779 - 199,189) 2016 Modelled IHME, GBD 2019 (accessed 2022)
178,463 (161,682 - 195,791) 2015 Modelled IHME, GBD 2019 (accessed 2022)
176,064 (159,899 - 192,839) 2014 Modelled IHME, GBD 2019 (accessed 2022)
173,504 (157,944 - 188,985) 2013 Modelled IHME, GBD 2019 (accessed 2022)
170,846 (155,367 - 185,999) 2012 Modelled IHME, GBD 2019 (accessed 2022)
168,711 (153,251 - 184,369) 2011 Modelled IHME, GBD 2019 (accessed 2022)
166,576 (150,323 - 182,821) 2010 Modelled IHME, GBD 2019 (accessed 2022)
164,893 (149,400 - 181,297) 2009 Modelled IHME, GBD 2019 (accessed 2022)
164,021 (148,130 - 181,280) 2008 Modelled IHME, GBD 2019 (accessed 2022)
163,365 (147,553 - 181,578) 2007 Modelled IHME, GBD 2019 (accessed 2022)
162,386 (145,780 - 182,100) 2006 Modelled IHME, GBD 2019 (accessed 2022)
160,659 (143,138 - 181,564) 2005 Modelled IHME, GBD 2019 (accessed 2022)
158,505 (142,115 - 178,738) 2004 Modelled IHME, GBD 2019 (accessed 2022)
156,487 (140,543 - 175,225) 2003 Modelled IHME, GBD 2019 (accessed 2022)
154,491 (139,110 - 172,267) 2002 Modelled IHME, GBD 2019 (accessed 2022)
152,395 (137,537 - 169,338) 2001 Modelled IHME, GBD 2019 (accessed 2022)
150,087 (135,089 - 167,133) 2000 Modelled IHME, GBD 2019 (accessed 2022)
147,950 (133,436 - 164,284) 1999 Modelled IHME, GBD 2019 (accessed 2022)
146,239 (131,867 - 162,549) 1998 Modelled IHME, GBD 2019 (accessed 2022)
144,613 (130,330 - 160,992) 1997 Modelled IHME, GBD 2019 (accessed 2022)
142,731 (127,959 - 160,002) 1996 Modelled IHME, GBD 2019 (accessed 2022)
140,290 (125,064 - 157,597) 1995 Modelled IHME, GBD 2019 (accessed 2022)
137,457 (122,764 - 153,993) 1994 Modelled IHME, GBD 2019 (accessed 2022)
134,582 (119,985 - 150,197) 1993 Modelled IHME, GBD 2019 (accessed 2022)
131,639 (116,884 - 146,738) 1992 Modelled IHME, GBD 2019 (accessed 2022)
128,606 (114,007 - 142,914) 1991 Modelled IHME, GBD 2019 (accessed 2022)
125,460 (110,788 - 139,755) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.49 (1.71 - 3.49) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.75 (3.04 - 4.68) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.6 (2.91 - 4.46) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.96 (3.26 - 4.84) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.03 (3.30 - 4.98) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.84 (3.09 - 4.73) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.12 (3.35 - 5.14) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.11 (3.41 - 5.04) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.96 (3.24 - 4.90) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.4 (2.67 - 4.24) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.84 (3.08 - 4.82) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.41 (2.67 - 4.37) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.21 (2.50 - 4.07) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.25 (2.56 - 4.06) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.23 (2.50 - 4.08) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.17 (2.41 - 4.09) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.14 (2.41 - 3.99) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.05 (2.33 - 3.92) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.89 (2.20 - 3.76) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.79 (2.13 - 3.60) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.93 (2.24 - 3.83) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.93 (2.20 - 3.86) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.88 (2.18 - 3.76) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.82 (2.18 - 3.64) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.75 (2.14 - 3.60) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.67 (2.05 - 3.46) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.63 (1.96 - 3.50) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.6 (1.88 - 3.57) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (1.80 - 3.61) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.53 (1.74 - 3.58) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (1.71 - 3.49) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
4,340 2016 Modelled WHO
815 (660 - 1,017) 1990 Modelled IHME, GBD 2019 (accessed 2022)
796 (644 - 987) 1991 Modelled IHME, GBD 2019 (accessed 2022)
939 (769 - 1,161) 1994 Modelled IHME, GBD 2019 (accessed 2022)
908 (747 - 1,109) 1993 Modelled IHME, GBD 2019 (accessed 2022)
865 (697 - 1,066) 1992 Modelled IHME, GBD 2019 (accessed 2022)
976 (794 - 1,216) 1995 Modelled IHME, GBD 2019 (accessed 2022)
987 (821 - 1,213) 1996 Modelled IHME, GBD 2019 (accessed 2022)
968 (790 - 1,196) 1997 Modelled IHME, GBD 2019 (accessed 2022)
952 (762 - 1,195) 1998 Modelled IHME, GBD 2019 (accessed 2022)
867 (680 - 1,081) 2000 Modelled IHME, GBD 2019 (accessed 2022)
858 (672 - 1,099) 1999 Modelled IHME, GBD 2019 (accessed 2022)
841 (661 - 1,049) 2001 Modelled IHME, GBD 2019 (accessed 2022)
842 (655 - 1,066) 2002 Modelled IHME, GBD 2019 (accessed 2022)
857 (664 - 1,084) 2003 Modelled IHME, GBD 2019 (accessed 2022)
852 (648 - 1,099) 2004 Modelled IHME, GBD 2019 (accessed 2022)
804 (612 - 1,048) 2007 Modelled IHME, GBD 2019 (accessed 2022)
854 (657 - 1,084) 2005 Modelled IHME, GBD 2019 (accessed 2022)
840 (643 - 1,078) 2006 Modelled IHME, GBD 2019 (accessed 2022)
787 (599 - 1,015) 2008 Modelled IHME, GBD 2019 (accessed 2022)
837 (639 - 1,092) 2009 Modelled IHME, GBD 2019 (accessed 2022)
846 (641 - 1,104) 2011 Modelled IHME, GBD 2019 (accessed 2022)
846 (636 - 1,116) 2010 Modelled IHME, GBD 2019 (accessed 2022)
847 (657 - 1,108) 2013 Modelled IHME, GBD 2019 (accessed 2022)
846 (653 - 1,092) 2012 Modelled IHME, GBD 2019 (accessed 2022)
843 (630 - 1,125) 2015 Modelled IHME, GBD 2019 (accessed 2022)
841 (648 - 1,092) 2014 Modelled IHME, GBD 2019 (accessed 2022)
848 (612 - 1,166) 2016 Modelled IHME, GBD 2019 (accessed 2022)
852 (597 - 1,199) 2017 Modelled IHME, GBD 2019 (accessed 2022)
852 (585 - 1,206) 2018 Modelled IHME, GBD 2019 (accessed 2022)
846 (581 - 1,186) 2019 Modelled IHME, GBD 2019 (accessed 2022)
846 (581 - 1,186) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
25 (19 - 30) 1990 Modelled IHME, GBD 2019 (accessed 2022)
24 (19 - 29) 1991 Modelled IHME, GBD 2019 (accessed 2022)
29 (23 - 35) 1993 Modelled IHME, GBD 2019 (accessed 2022)
27 (21 - 33) 1992 Modelled IHME, GBD 2019 (accessed 2022)
31 (25 - 38) 1994 Modelled IHME, GBD 2019 (accessed 2022)
32 (26 - 39) 1995 Modelled IHME, GBD 2019 (accessed 2022)
35 (28 - 42) 1996 Modelled IHME, GBD 2019 (accessed 2022)
30 (24 - 37) 1998 Modelled IHME, GBD 2019 (accessed 2022)
32 (26 - 39) 1997 Modelled IHME, GBD 2019 (accessed 2022)
25 (20 - 30) 2000 Modelled IHME, GBD 2019 (accessed 2022)
25 (20 - 30) 1999 Modelled IHME, GBD 2019 (accessed 2022)
25 (20 - 30) 2001 Modelled IHME, GBD 2019 (accessed 2022)
24 (19 - 29) 2002 Modelled IHME, GBD 2019 (accessed 2022)
23 (19 - 28) 2003 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 28) 2004 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 27) 2007 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 28) 2005 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 28) 2006 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 27) 2008 Modelled IHME, GBD 2019 (accessed 2022)
21 (17 - 27) 2009 Modelled IHME, GBD 2019 (accessed 2022)
21 (17 - 27) 2010 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 27) 2011 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 27) 2012 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 27) 2013 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 28) 2014 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2015 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2016 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2017 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2018 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 30) 2019 Modelled IHME, GBD 2019 (accessed 2022)
40 (32 - 50) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
82 2019 Survey/reported WHO/UNICEF
73 2018 Survey/reported WHO/UNICEF
75 2017 Survey/reported WHO/UNICEF
79 2016 Survey/reported WHO/UNICEF
79 2015 Survey/reported WHO/UNICEF
78 2014 Survey/reported WHO/UNICEF
82 2013 Survey/reported WHO/UNICEF
81 2012 Survey/reported WHO/UNICEF
76 2011 Survey/reported WHO/UNICEF
74 2010 Survey/reported WHO/UNICEF
71 2009 Survey/reported WHO/UNICEF
79 2008 Survey/reported WHO/UNICEF
73 2007 Survey/reported WHO/UNICEF
66 2006 Survey/reported WHO/UNICEF
67 2005 Survey/reported WHO/UNICEF
68 2004 Survey/reported WHO/UNICEF
60 2003 Survey/reported WHO/UNICEF
77 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
88 2019 Survey/reported WHO/UNICEF
82 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Partially Adopted
System for monitoring testing and treatment
Not Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Recommendations for HBV testing of pregnant women
Adopted
Licensed point-of-care PCR testing to detect HBV
Adopted
Eligible for HBV generic medicines
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
System for monitoring testing and treatment
Not Adopted
Recommendations for HCV testing of pregnant women
Not Adopted
HCV testing policy
Risk-based
National treatment guidelines exist
Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
No fibrosis restrictions
Adopted
No sobriety restrictions
Adopted
Eligible for HCV generic medicines
Yes
Registration of originator HCV DAAs
Adopted
Licensed point-of-care PCR testing to detect HCV
Adopted
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
No
% of substance use disorder facilities offering hepatitis treatment
No
Public budget line for testing and treatment
Adopted

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.5 (0.30 - 0.60) 2015 Modelled Blach et al, 2017
0.1 2015 Survey/reported Cabezas C, Trujillo O, Gonzales-Vivanco Á, et al.
1.05 (0.85 - 1.31) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.84 - 1.31) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.84 - 1.30) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.84 - 1.30) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.84 - 1.29) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.84 - 1.29) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.84 - 1.30) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.85 - 1.30) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.85 - 1.31) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.84 - 1.30) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.83 - 1.29) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.81 - 1.25) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.79 - 1.22) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.78 - 1.18) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.76 - 1.16) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.76 - 1.16) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.75 - 1.15) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.75 - 1.15) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.75 - 1.14) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.75 - 1.14) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.75 - 1.15) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.77 - 1.18) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.79 - 1.21) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.23) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.81 - 1.24) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.81 - 1.24) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.80 - 1.23) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.80 - 1.23) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.80 - 1.22) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.79 - 1.22) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.80 - 1.24) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.52 (0.31 - 0.56) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.2 (0.40 - 1.60) 2014 Survey/reported Gower et al, 2014
1.16 2019 Modelled Jin et al. 2017
0.1 (0.02 - 0.20) 2015 Survey/reported Cabezas, C., et al. 2020
Showing out of
Show more
Technical notes

Number of persons living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
167,000 (99,000 - 182,000) 2015 Modelled Blach et al, 2017
203,575 (163,058 - 253,738) 1990 Modelled IHME, GBD 2019 (accessed 2022)
208,488 (167,805 - 258,621) 1991 Modelled IHME, GBD 2019 (accessed 2022)
213,152 (171,759 - 263,013) 1992 Modelled IHME, GBD 2019 (accessed 2022)
217,584 (175,575 - 270,369) 1993 Modelled IHME, GBD 2019 (accessed 2022)
221,802 (179,012 - 275,403) 1994 Modelled IHME, GBD 2019 (accessed 2022)
225,821 (182,846 - 280,041) 1995 Modelled IHME, GBD 2019 (accessed 2022)
227,947 (184,975 - 282,096) 1996 Modelled IHME, GBD 2019 (accessed 2022)
227,447 (183,887 - 282,094) 1997 Modelled IHME, GBD 2019 (accessed 2022)
225,851 (181,942 - 278,787) 1998 Modelled IHME, GBD 2019 (accessed 2022)
224,878 (181,486 - 276,160) 1999 Modelled IHME, GBD 2019 (accessed 2022)
226,352 (182,555 - 278,792) 2000 Modelled IHME, GBD 2019 (accessed 2022)
229,733 (184,791 - 283,214) 2001 Modelled IHME, GBD 2019 (accessed 2022)
233,307 (188,738 - 287,181) 2002 Modelled IHME, GBD 2019 (accessed 2022)
237,113 (190,994 - 291,235) 2003 Modelled IHME, GBD 2019 (accessed 2022)
241,230 (194,554 - 296,067) 2004 Modelled IHME, GBD 2019 (accessed 2022)
245,765 (198,126 - 301,146) 2005 Modelled IHME, GBD 2019 (accessed 2022)
252,316 (203,781 - 309,650) 2006 Modelled IHME, GBD 2019 (accessed 2022)
261,492 (210,929 - 321,986) 2007 Modelled IHME, GBD 2019 (accessed 2022)
271,690 (218,565 - 335,505) 2008 Modelled IHME, GBD 2019 (accessed 2022)
281,307 (226,232 - 348,018) 2009 Modelled IHME, GBD 2019 (accessed 2022)
288,771 (231,597 - 357,289) 2010 Modelled IHME, GBD 2019 (accessed 2022)
294,347 (236,452 - 364,439) 2011 Modelled IHME, GBD 2019 (accessed 2022)
299,868 (241,477 - 371,713) 2012 Modelled IHME, GBD 2019 (accessed 2022)
306,206 (247,133 - 378,471) 2013 Modelled IHME, GBD 2019 (accessed 2022)
312,283 (252,374 - 385,812) 2014 Modelled IHME, GBD 2019 (accessed 2022)
317,973 (256,584 - 393,474) 2015 Modelled IHME, GBD 2019 (accessed 2022)
322,676 (261,524 - 402,893) 2016 Modelled IHME, GBD 2019 (accessed 2022)
328,700 (264,964 - 411,047) 2017 Modelled IHME, GBD 2019 (accessed 2022)
334,810 (271,288 - 420,387) 2018 Modelled IHME, GBD 2019 (accessed 2022)
338,348 (273,114 - 422,515) 2019 Modelled IHME, GBD 2019 (accessed 2020)
340,272 (274,868 - 424,634) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
44,600 (26,400 - 48,500) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
2.61 (1.66 - 3.92) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.48 (1.80 - 3.40) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.34 (1.69 - 3.19) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (1.86 - 3.40) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (1.91 - 3.47) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (1.81 - 3.34) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.61 (1.94 - 3.48) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (1.92 - 3.46) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (1.92 - 3.50) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.48 (1.81 - 3.44) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (1.89 - 3.50) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.48 (1.77 - 3.36) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.38 (1.76 - 3.29) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.36 (1.71 - 3.32) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.37 (1.73 - 3.33) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.33 (1.66 - 3.24) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.3 (1.67 - 3.19) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.32 (1.69 - 3.17) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.27 (1.63 - 3.12) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.31 (1.64 - 3.12) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (1.80 - 3.51) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (1.84 - 3.61) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.51 (1.80 - 3.52) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.61 (1.84 - 3.70) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (1.84 - 3.56) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.43 (1.69 - 3.44) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.44 (1.75 - 3.42) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.45 (1.64 - 3.58) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (1.64 - 3.62) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.61 (1.66 - 3.92) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (1.65 - 3.76) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
603 2016 Modelled WHO
887 (563 - 1,334) 2019 Modelled IHME, GBD 2019 (accessed 2022)
887 (563 - 1,334) 2019 Modelled IHME, GBD 2019 (accessed 2020)
856 (554 - 1,266) 2018 Modelled IHME, GBD 2019 (accessed 2022)
828 (545 - 1,202) 2017 Modelled IHME, GBD 2019 (accessed 2022)
800 (535 - 1,166) 2016 Modelled IHME, GBD 2019 (accessed 2022)
779 (543 - 1,103) 2015 Modelled IHME, GBD 2019 (accessed 2022)
770 (550 - 1,079) 2014 Modelled IHME, GBD 2019 (accessed 2022)
773 (555 - 1,083) 2013 Modelled IHME, GBD 2019 (accessed 2022)
771 (551 - 1,068) 2012 Modelled IHME, GBD 2019 (accessed 2022)
766 (540 - 1,086) 2011 Modelled IHME, GBD 2019 (accessed 2022)
757 (531 - 1,045) 2010 Modelled IHME, GBD 2019 (accessed 2022)
726 (512 - 1,000) 2009 Modelled IHME, GBD 2019 (accessed 2022)
650 (462 - 880) 2008 Modelled IHME, GBD 2019 (accessed 2022)
633 (454 - 868) 2007 Modelled IHME, GBD 2019 (accessed 2022)
634 (459 - 878) 2006 Modelled IHME, GBD 2019 (accessed 2022)
630 (461 - 861) 2005 Modelled IHME, GBD 2019 (accessed 2022)
626 (446 - 872) 2004 Modelled IHME, GBD 2019 (accessed 2022)
630 (460 - 883) 2003 Modelled IHME, GBD 2019 (accessed 2022)
618 (447 - 870) 2002 Modelled IHME, GBD 2019 (accessed 2022)
616 (455 - 851) 2001 Modelled IHME, GBD 2019 (accessed 2022)
634 (461 - 879) 2000 Modelled IHME, GBD 2019 (accessed 2022)
623 (444 - 845) 1999 Modelled IHME, GBD 2019 (accessed 2022)
641 (469 - 867) 1998 Modelled IHME, GBD 2019 (accessed 2022)
631 (468 - 854) 1997 Modelled IHME, GBD 2019 (accessed 2022)
620 (463 - 831) 1996 Modelled IHME, GBD 2019 (accessed 2022)
618 (459 - 825) 1995 Modelled IHME, GBD 2019 (accessed 2022)
597 (445 - 809) 1994 Modelled IHME, GBD 2019 (accessed 2022)
584 (427 - 779) 1993 Modelled IHME, GBD 2019 (accessed 2022)
560 (408 - 752) 1992 Modelled IHME, GBD 2019 (accessed 2022)
518 (375 - 706) 1991 Modelled IHME, GBD 2019 (accessed 2022)
539 (390 - 739) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
4 (2 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 8) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2019 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Partially Adopted
System for monitoring testing and treatment
Not Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Recommendations for HBV testing of pregnant women
Adopted
Licensed point-of-care PCR testing to detect HBV
Adopted
Eligible for HBV generic medicines
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
System for monitoring testing and treatment
Not Adopted
Recommendations for HCV testing of pregnant women
Not Adopted
HCV testing policy
Risk-based
National treatment guidelines exist
Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
No fibrosis restrictions
Adopted
No sobriety restrictions
Adopted
Eligible for HCV generic medicines
Yes
Registration of originator HCV DAAs
Adopted
Licensed point-of-care PCR testing to detect HCV
Adopted
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
No
% of substance use disorder facilities offering hepatitis treatment
No
Public budget line for testing and treatment
Adopted

Overview

Resources